title: Update on prostaglandin analogs.
abstract: Prostaglandin analogs are a novel class of intraocular-lowering medications used primarily for the treatment of glaucoma. These topical medications reduce intraocular pressure primarily by enhancing uveoscleral outflow. The recent literature has enhanced our understanding of the mechanism of action, efficacy, and safety of these agents and has allowed us to better understand the differences between the three commonly used once-daily medications.
authors.affiliation: The Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA.
authors.forename: Camille
authors.initials: C
authors.lastname: Hylton
authors.forename: Alan L
authors.initials: AL
authors.lastname: Robin
mesh_terms: D000287:Administration, Topical; D000577:Amides; D000069580:Bimatoprost; D003008:Cloprostenol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D000077338:Latanoprost; D008055:Lipids / Q000627:therapeutic use; D009798:Ocular Hypertension / Q000188:drug therapy*; D011453:Prostaglandins / Q000008:administration & dosage / Q000627:therapeutic use*; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use; D012449:Safety; D000069557:Travoprost
chemical_list: D000577:Amides; D008055:Lipids; D011453:Prostaglandins; D011461:Prostaglandins F, Synthetic; D003008:Cloprostenol; D000077338:Latanoprost; D000069580:Bimatoprost; D000069557:Travoprost